Literature DB >> 24299739

Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Fabrizio Rinaldi1, Rita C R Perlingeiro2.   

Abstract

Conditions involving muscle wasting, such as muscular dystrophies, cachexia, and sarcopenia, would benefit from approaches that promote skeletal muscle regeneration. Stem cells are particularly attractive because they are able to differentiate into specialized cell types while retaining the ability to self-renew and, thus, provide a long-term response. This review will discuss recent advancements on different types of stem cells that have been attributed to be endowed with muscle regenerative potential. We will discuss the nature of these cells and their advantages and disadvantages in regards to therapy for muscular dystrophies.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24299739      PMCID: PMC3976768          DOI: 10.1016/j.trsl.2013.11.006

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  130 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  A common precursor for primitive erythropoiesis and definitive haematopoiesis.

Authors:  M Kennedy; M Firpo; K Choi; C Wall; S Robertson; N Kabrun; G Keller
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

3.  Culturing satellite cells from living single muscle fiber explants.

Authors:  J D Rosenblatt; A I Lunt; D J Parry; T A Partridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

4.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

5.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

6.  Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.

Authors:  Francesco Saverio Tedesco; Mattia F M Gerli; Laura Perani; Sara Benedetti; Federica Ungaro; Marco Cassano; Stefania Antonini; Enrico Tagliafico; Valentina Artusi; Emanuela Longa; Rossana Tonlorenzi; Martina Ragazzi; Giorgia Calderazzi; Hidetoshi Hoshiya; Ornella Cappellari; Marina Mora; Benedikt Schoser; Peter Schneiderat; Mitsuo Oshimura; Roberto Bottinelli; Maurilio Sampaolesi; Yvan Torrente; Vania Broccoli; Giulio Cossu
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

7.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Satellite cells and myonuclei in young and elderly women and men.

Authors:  Fawzi Kadi; Nadia Charifi; Christian Denis; Jan Lexell
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

9.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

10.  Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells.

Authors:  Frédéric Relaix; Didier Montarras; Stéphane Zaffran; Barbara Gayraud-Morel; Didier Rocancourt; Shahragim Tajbakhsh; Ahmed Mansouri; Ana Cumano; Margaret Buckingham
Journal:  J Cell Biol       Date:  2005-12-27       Impact factor: 10.539

View more
  28 in total

Review 1.  Ultrasound-guided procedures to treat sport-related muscle injuries.

Authors:  Davide Orlandi; Angelo Corazza; Alice Arcidiacono; Carmelo Messina; Giovanni Serafini; Luca M Sconfienza; Enzo Silvestri
Journal:  Br J Radiol       Date:  2015-11-12       Impact factor: 3.039

Review 2.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

3.  Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes.

Authors:  Nunnapas Jiwlawat; Eileen M Lynch; Brett N Napiwocki; Alana Stempien; Randolph S Ashton; Timothy J Kamp; Wendy C Crone; Masatoshi Suzuki
Journal:  Biotechnol Bioeng       Date:  2019-06-20       Impact factor: 4.530

4.  In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.

Authors:  Yasuyuki Mitani; Ronald J Vagnozzi; Douglas P Millay
Journal:  FASEB J       Date:  2016-10-17       Impact factor: 5.191

Review 5.  Coaxing stem cells for skeletal muscle repair.

Authors:  Karl J A McCullagh; Rita C R Perlingeiro
Journal:  Adv Drug Deliv Rev       Date:  2014-07-15       Impact factor: 15.470

6.  Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture.

Authors:  Saowanee Jiwlawat; Eileen Lynch; Jennifer Glaser; Ivy Smit-Oistad; Jeremy Jeffrey; Jonathan M Van Dyke; Masatoshi Suzuki
Journal:  Differentiation       Date:  2017-08-01       Impact factor: 3.880

7.  Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.

Authors:  Rui Xu; Neha Singhal; Yelda Serinagaoglu; Kumaran Chandrasekharan; Mandar Joshi; John A Bauer; Paulus M L Janssen; Paul T Martin
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

8.  Injectable biomimetic liquid crystalline scaffolds enhance muscle stem cell transplantation.

Authors:  Eduard Sleep; Benjamin D Cosgrove; Mark T McClendon; Adam T Preslar; Charlotte H Chen; M Hussain Sangji; Charles M Rubert Pérez; Russell D Haynes; Thomas J Meade; Helen M Blau; Samuel I Stupp
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

9.  Identification of Skeletal Muscle Satellite Cells by Immunofluorescence with Pax7 and Laminin Antibodies.

Authors:  Xuesong Feng; Faiza Naz; Aster H Juan; Stefania Dell'Orso; Vittorio Sartorelli
Journal:  J Vis Exp       Date:  2018-04-19       Impact factor: 1.355

10.  Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.

Authors:  Robert N Judson; Marco Quarta; Menno J Oudhoff; Hesham Soliman; Lin Yi; Chih Kai Chang; Gloria Loi; Ryan Vander Werff; Alissa Cait; Mark Hamer; Justin Blonigan; Patrick Paine; Linda T N Doan; Elena Groppa; WenJun He; Le Su; Regan H Zhang; Peter Xu; Christine Eisner; Marcela Low; Ingrid Barta; Coral-Ann B Lewis; Colby Zaph; Mohammad M Karimi; Thomas A Rando; Fabio M Rossi
Journal:  Cell Stem Cell       Date:  2018-01-25       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.